Therefore, NEDD4 targets PD-L1 for ubiquitination and destruction in FGFR3-overexpressing bladder cancer, indicating that NEDD4 is associated with immune surveillance via regulation of PD-L1 in bladder cancer (120). The gene discussed is NEDD4; the disease is urinary bladder carcinoma.